|
ACTH, pmol/L
|
3.1 (1.1–18.0)
|
1.5 (1.1–15.0)
|
6.0 (1.1–14.0)
|
3.8 (1.0–8.9)
|
0.001, 0.025, 0.72
|
|
Baseline cortisol, nmol/L
|
470 (200–1355)
|
430 (75–2670)
|
655 (335–1890)
|
495 (35–2670)
|
0.021, 0.12, 0.30
|
|
Baseline cortisol/ACTH, nmol/pmol
|
148 (36–250)
|
238 (14–2054)
|
109 (48–1718)
|
126 (35–2054)
|
0.029, 0.16, 0.14
|
|
Baseline free cortisol, nmol/L
|
77 (63–357) (n=9)
|
86 (38–256) (n=14)
|
154 (114–252) (n=6)
|
75 (4–151) (n=20)
|
0.001, 0.91, 0.19
|
|
Baseline free cortisol/ACTH, nmol/pmol
|
22 (9–38)
|
39 (16–89)
|
26 (11–43)
|
17 (4–35)
|
0.042, 0.10, <0.001
|
|
Δ cortisol, nmol/L
|
140 (−50–245)
|
388 (260–4015)
|
177 (−80–230)
|
425 (255–965)
|
n.a., 0.45, 0.093
|
|
Δ free cortisol, nmol/L
|
59 (−71–124)
|
151 (74–678)
|
40 (−34–99)
|
133 (32–233)
|
<0.001, 0.15, 0.16
|
|
CBG, mg/L
|
23 (6–43)
|
29 (13–63)
|
39 (4–60)
|
41 (21–65)
|
0.060, <0.001, 0.90
|
|
Albumin, g/L
|
13 (6–32)
|
17 (6–24)
|
16 (12–28)
|
20 (8–32)
|
0.25, <0.001, 0.89
|
|
Days from admission - test
|
1 (0–50)
|
3 (0–44)
|
25 (9–49)
|
20 (9–83)
|
0.57*, 0.15*
|
|
Days between tests
|
n.a.
|
n.a.
|
18 (8–34)
|
16 (8–43)
|
0.41*
|
|
Days after stop hydrocortisone
|
n.a.
|
n.a.
|
7 (5–12)
|
7 (5–14)
|
0.75*
|
